| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年5月 |
CRISPR Market – Global Forecast to 2030
CRISPR 市場レポートは、提供内容 [製品 (CRISPR キットおよび酵素、CRISPR ライブラリ、およびその他の製品)、サービス (gRNA 合成および細胞株開発、スクリーニングおよび検証、およびその他のサービス)]、アプリケーション (医薬品の発見および開発、農業、およびその他のアプリケーション)、およびエンドユーザー [製品 (製薬およびバイオテクノロジー企業、学術および研究機関、およびその他のエンドユーザー)、およびサービス (製薬およびバイオテクノロジー企業、学術および研究機関、およびその他のエンドユーザー)] に基づいてセグメント化されています。
The global CRISPR market is anticipated to reach USD 5.47 billion by 2030 from USD 3.21 billion in 2025, at a significant CAGR of 11.2%.
世界の CRISPR 市場は、2025 年の 32 億 1,000 万米ドルから 2030 年までに 54 億 7,000 万米ドルに達し、11.2% という大幅な CAGR で成長すると予想されています。
The CRISPR market is experiencing substantial growth, with a notable CAGR driven by its increasing adoption in research, clinical, and industrial applications. Several factors contribute to this market expansion, including the rising prevalence of genetic disorders, the growing use of CRISPR in drug discovery and gene therapy, and increased investments in biotechnology research and development. Additionally, advancements in CRISPR tools, improved delivery systems, and supportive regulatory developments further accelerate its integration into mainstream research and therapeutic pipelines.
CRISPR市場は大幅な成長を遂げており、研究、臨床、産業用途における採用の増加に牽引され、顕著なCAGR（年平均成長率）を記録しています。この市場拡大には、遺伝性疾患の罹患率の上昇、創薬および遺伝子治療におけるCRISPRの利用拡大、バイオテクノロジー研究開発への投資増加など、複数の要因が寄与しています。さらに、CRISPRツールの進歩、デリバリーシステムの改善、そしてそれを支える規制の整備により、CRISPRは主流の研究・治療パイプラインへの統合がさらに加速しています。
The prominent players operating in the CRISPR market are Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), GenScript (US), Takara Bio (Japan), Creative Biogene (US), Fujian SunyBiotech Co., Ltd. (China), EditCo (US), Caribou Biosciences, Inc. (US), Lonza Group (Switzerland), Danaher Corporation (US), Revvity, Inc. (US), Hera BioLabs (US), OriGene Technologies, Inc. (US), Cellecta, Inc. (US), Mammoth Biosciences, Inc. (US), Applied StemCell (US), New England Biolabs Inc. (US), ToolGen Inc. (South Korea), GeneCopoeia, Inc. (US), Twist Bioscience Corporation (US), Synthego Corporation (US), eGenesis (US), Inscripta, Inc. (US), and Precision BioSciences, Inc. (US), among others.
The report provides insights into the following pointers:
- Analysis of key drivers (growing demand for CRISPR-based gene therapies, advancements in CRISPR technology, and growing government and private investments and funding for CRISPR technology), restraints (technical challenges associated with CRISPR technology), opportunities (development of new vaccines and treatments for genetic diseases and expanding industrial and agricultural applications of CRISPR), and challenges (regulatory hurdles for CRISPR advancements) influencing the growth of the market.
- Product Development/Innovation: In-depth analysis of emerging technologies in CRISPR, R&D activities, and new product launches in the CRISPR market.
- Market Development: The report provides detailed information about profitable markets and analyzes the market conditions across various regions.
- Market Diversification: Comprehensive information about new products, unexplored regions, recent updates, and investments in the CRISPR market.
- Competitive Assessment: Comprehensive evaluation of market shares, growth strategies, and product & service offerings of leading companies such as Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), and GenScript (US).